SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-026656
Filing Date
2017-05-12
Accepted
2017-05-12 09:12:42
Documents
35
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v465943_10-q.htm 10-Q 302496
2 EXHIBIT 31.1 v465943_ex31-1.htm EX-31.1 8738
3 EXHIBIT 31.2 v465943_ex31-2.htm EX-31.2 8626
4 EXHIBIT 32 v465943_ex32.htm EX-32 6041
  Complete submission text file 0001144204-17-026656.txt   1767413

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT relv-20170331.xml EX-101.INS 276123
6 XBRL TAXONOMY EXTENSION SCHEMA relv-20170331.xsd EX-101.SCH 17474
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE relv-20170331_cal.xml EX-101.CAL 40917
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE relv-20170331_def.xml EX-101.DEF 100631
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE relv-20170331_lab.xml EX-101.LAB 159819
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE relv-20170331_pre.xml EX-101.PRE 119930
Mailing Address 136 CHESTERFIELD INDUSTRIAL BLVD P O BOX 405 CHESTERFIELD MO 63006-0405
Business Address 136 CHESTERFIELD INDUSTRIAL BLVD P O BOX 405 CHESTERFIELD MO 63006-0405 636-537-9715
RELIV INTERNATIONAL INC (Filer) CIK: 0000768710 (see all company filings)

IRS No.: 371172197 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19932 | Film No.: 17836589
SIC: 2834 Pharmaceutical Preparations